Skip to content
10-Q

Quarterly Report

ALDEYRA THERAPEUTICS, INC. ALDX

0000950170-25-104971

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 59.9M sh
Shares Diluted Q2 2025 · Jun 30, 2025 60.05M sh
Shares Diluted Q2 2025 · Jun 30, 2025 59.97M sh
Shares Diluted Q2 2025 · Jun 30, 2024 59.41M sh
Shares Diluted Q2 2025 · Jun 30, 2024 59.41M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$21.02M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$23.2M
Long Term Debt Q2 2025 · Jun 30, 2025 $0
Long Term Debt Q2 2025 · Dec 31, 2024 $15M
Short Term Debt Q2 2025 · Jun 30, 2025 $15.15M
Short Term Debt Q2 2025 · Dec 31, 2024 $31.37K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $41.24M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $54.53M
Stockholders Equity Q2 2025 · Jun 30, 2025 $55.29M
Stockholders Equity Q2 2025 · Mar 31, 2025 $63.6M
Stockholders Equity Q2 2025 · Dec 31, 2024 $71M
Stockholders Equity Q2 2025 · Jun 30, 2024 $98.31M
Stockholders Equity Q2 2025 · Mar 31, 2024 $113.42M
Stockholders Equity Q2 2025 · Dec 31, 2023 $119.8M
Current Liabilities Q2 2025 · Jun 30, 2025 $29.53M
Current Liabilities Q2 2025 · Dec 31, 2024 $18.6M
Total Liabilities Q2 2025 · Jun 30, 2025 $29.67M
Total Liabilities Q2 2025 · Dec 31, 2024 $33.6M
Current Assets Q2 2025 · Jun 30, 2025 $84.56M
Current Assets Q2 2025 · Dec 31, 2024 $104.07M
Total Assets Q2 2025 · Jun 30, 2025 $84.96M
Total Assets Q2 2025 · Dec 31, 2024 $104.61M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.16
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.33
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.28
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.42
Eps Basic Q2 2025 · Jun 30, 2025 −$0.16
Eps Basic Q2 2025 · Jun 30, 2025 −$0.33
Eps Basic Q2 2025 · Jun 30, 2024 −$0.28
Eps Basic Q2 2025 · Jun 30, 2024 −$0.42
Sga Expense Q2 2025 · Jun 30, 2025 $1.66M
Sga Expense Q2 2025 · Jun 30, 2025 $4.67M
Sga Expense Q2 2025 · Jun 30, 2024 $3.04M
Sga Expense Q2 2025 · Jun 30, 2024 $6.25M
Rd Expense Q2 2025 · Jun 30, 2025 $8.51M
Rd Expense Q2 2025 · Jun 30, 2025 $15.93M
Rd Expense Q2 2025 · Jun 30, 2024 $14.97M
Rd Expense Q2 2025 · Jun 30, 2024 $21.15M
Net Income Q2 2025 · Jun 30, 2025 −$9.77M
Net Income Q2 2025 · Jun 30, 2025 −$19.7M
Net Income Q2 2025 · Jun 30, 2024 −$16.85M
Net Income Q2 2025 · Jun 30, 2024 −$24.93M
Operating Income Q2 2025 · Jun 30, 2025 −$10.17M
Operating Income Q2 2025 · Jun 30, 2025 −$20.6M
Operating Income Q2 2025 · Jun 30, 2024 −$18.01M
Operating Income Q2 2025 · Jun 30, 2024 −$27.4M